PAG
BNTC icon

Private Advisor Group’s Benitec Biopharma BNTC Stock Holding History

Private Advisor Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-774
Closed -$3.14K – 2301
2023
Q2 		$3.14K Hold
774
– – ﹤0.01% 2017
2023
Q1 		$2.76K Buy
+774
New +$3.15K ﹤0.01% 1957

Other funds holding BNTC

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Private Advisor Group's BNTC Position: Q3 2023 in Review

Private Advisor Group sold out of Benitec Biopharma (BNTC) in Q3 2023, closing a stake of 774 shares — an estimated $3.14K sold.

Private Advisor Group first reported a position in BNTC in Q1 2023 and held it in 2 quarters. The position peaked at $3.14K in Q2 2023. 12 funds tracked by Wall St. Rank hold BNTC as of Q3 2023.

  • Private Advisor Group reported no remaining Benitec Biopharma position as of Q3 2023 after selling out during the quarter.
  • Private Advisor Group sold 774 Benitec Biopharma shares in Q3 2023, an estimated $3.14K.
  • Private Advisor Group first reported a position in Benitec Biopharma in Q1 2023 and held it in 2 quarters.
  • Private Advisor Group's Benitec Biopharma position peaked at $3.14K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2023.

Based on Private Advisor Group's 13F filing for Q3 2023, filed 3 Nov 2023.